| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.46 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.42 | 0.002 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.41 | 0.007 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 3e-05 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 5e-05 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |